1. Emerging Role of Wnt/Beta-Catenin Signalling Pathways in Cancer Progression and Role of Small Molecule Tankyrase Inhibitors in Combating Multistage Cancers
    Babli Khatun et al, 2021, Current Cancer Therapy Reviews CrossRef
  2. Bioinformatic Analysis of the Nicotinamide Binding Site in Poly(ADP-Ribose) Polymerase Family Proteins
    Garri Manasaryan et al, 2021, Cancers CrossRef
  3. Wnt Signaling and Its Significance Within the Tumor Microenvironment: Novel Therapeutic Insights
    Sonal Patel et al, 2019, Frontiers in Immunology CrossRef
  4. Tankyrase inhibitor XAV-939 enhances osteoblastogenesis and mineralization of human skeletal (mesenchymal) stem cells
    Nuha Almasoud et al, 2020, Scientific Reports CrossRef
  5. Unravelling the Mechanistic Role of Quinazolinone Pharmacophore in the Inhibitory Activity of Bis-quinazolinone Derivative on Tankyrase-1 in the Treatment of Colorectal Cancer (CRC) and Non-small Cell Lung Cancer (NSCLC): A Computational Approach
    Felix O. Okunlola et al, 2022, Cell Biochemistry and Biophysics CrossRef
  6. Zoning in on Tankyrases: A Brief Review on the Past, Present and Prospective Studies
    Xylia Q. Peters et al, 2020, Anti-Cancer Agents in Medicinal Chemistry CrossRef
  7. Tankyrase Regulates Neurite Outgrowth through Poly(ADP-ribosyl)ation-Dependent Activation of β-Catenin Signaling
    Masato Mashimo et al, 2022, International Journal of Molecular Sciences CrossRef
  8. Exploring the Wnt Pathway as a Therapeutic Target for Prostate Cancer
    Sarah Koushyar et al, 2022, Biomolecules CrossRef
  9. From PARP1 to TNKS2 Inhibition: A Structure-Based Approach
    Stefano Tomassi et al, 2020, ACS Medicinal Chemistry Letters CrossRef
  10. A Small-Molecule Tankyrase Inhibitor Reduces Glioma Stem Cell Proliferation and Sphere Formation
    Kirsten Strømme Kierulf-Vieira et al, 2020, Cancers CrossRef
  11. Poly(ADP-Ribose) Glycohydrolase (PARG) vs. Poly(ADP-Ribose) Polymerase (PARP) – Function in Genome Maintenance and Relevance of Inhibitors for Anti-cancer Therapy
    Daniel Harrision et al, 2020, Frontiers in Molecular Biosciences CrossRef
  12. A New Synthesis of Poly Heterocyclic Compounds Containing [1,2,4]triazolo and [1,2,3,4]tetrazolo Moieties and their DFT Study as Expected Anti-cancer Reagents
    El-sayed M. Abdelrehim et al, 2020, Current Organic Synthesis CrossRef
  13. Tankyrases as modulators of pro-tumoral functions: molecular insights and therapeutic opportunities
    Esteban Zamudio-Martinez et al, 2021, Journal of Experimental & Clinical Cancer Research CrossRef
  14. Tankyrase (PARP5) Inhibition Induces Bone Loss through Accumulation of Its Substrate SH3BP2
    Tomoyuki Mukai et al, 2019, Cells CrossRef
  15. The Role of PARPs in Inflammation—and Metabolic—Related Diseases: Molecular Mechanisms and Beyond
    null Ke et al, 2019, Cells CrossRef
  16. Preclinical Lead Optimization of a 1,2,4-Triazole Based Tankyrase Inhibitor
    Jo Waaler et al, 2020, Journal of Medicinal Chemistry CrossRef
  17. Poly (ADP-ribose) polymerase (PARP) inhibition in cancer: Potential impact in cancer stem cells and therapeutic implications
    Asim Rizvi et al, 2021, European Journal of Pharmacology CrossRef
  18. Unravelling the Structural Mechanism of Action of 5-methyl-5-[4-(4-oxo-3H-quinazolin-2-yl)phenyl]imidazolidine-2,4-dione in Dual-Targeting Tankyrase 1 and 2: A Novel Avenue in Cancer Therapy
    Xylia Q. Peters et al, 2022, Cell Biochemistry and Biophysics CrossRef